NYSE

CNO Financial Group, Inc. (CNO)

β™₯ 675 Thanks from members

CNO Financial Group exhibits robust operating momentum with record Q2 2026 revenue, a 16-quarter sales streak, and raised EPS guidance, though analysts debate whether a premium valuation leaves a sufficient margin of safety.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore β†’